1
/
of
0
FDA Drug Approval, N206927, BORTEZOMIB
FDA Drug Approval, N206927, BORTEZOMIB
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 206927
Company: DR REDDYS
Drug Name: BORTEZOMIB
Active Ingredients: BORTEZOMIB
Strength: 3.5MG/VIAL
Dosage Form/Route: POWDER;INTRAVENOUS
Action Date: 10/04/2019
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: DR REDDYS
Drug Name: BORTEZOMIB
Active Ingredients: BORTEZOMIB
Strength: 3.5MG/VIAL
Dosage Form/Route: POWDER;INTRAVENOUS
Action Date: 10/04/2019
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details